Vox Markets Logo
Directors back Argentex after strong FY24 results, CEO Ormonde invests £150k amid growth plans

Directors back Argentex after strong FY24 results, CEO Ormonde invests £150k amid growth plans

2 hours ago

Five directors, including CEO Jim Ormonde, have made substantial investments in Argentex following the group's positive FY24 results, as it prepares to launch new services aimed at expanding its forex and treasury solutions.

  • Science Group further increases stake in Ricardo

    3 hours ago

    Science Group announced on Friday that it has further increased its stake in Ricardo to 19.09%, intensifying pressure on the engineering consultancy's board following a series of scathing critiques of its governance and strategic decisions.

  • BP chair to step down next year

    3 hours ago

    The chair of BP is to step down, the oil and gas major announced on Friday, amid calls by investor groups for a shake-up of the board.

  • London open: FTSE falls as Trump tariffs fuel recession fears; payrolls eyed

    4 hours ago

    London stocks suffered more losses in early trade on Friday as Trump's sweeping tariffs fuelled recession fears, and as investors eyed the release of the latest US non-farm payrolls report.

  • London pre-open: Stocks to edge lower after Thursday's selloff; payrolls in focus

    5 hours ago

    London stocks were set to edge lower at the open on Friday following heavy losses a day earlier, as investors continued to assess the impact of Trump's bombshell tariff announcement and eyed the latest US non-farm payrolls report.

World Chess launches "Brains Are Duty-Free" discount campaign in response to US tariffs

World Chess launches "Brains Are Duty-Free" discount campaign in response to US tariffs

3 hours ago

World Chess's new "Brains Are Duty-Free" campaign offers discounts matching new US tariff rates to players in affected regions to boost engagement in key growth markets.

Todays Top RNS's from Vox Markets: Narf Industries, Solvonis Therapeutic, BP & More

Todays Top RNS's from Vox Markets: Narf Industries, Solvonis Therapeutic, BP & More

3 hours ago

Todays Top RNS's from Vox Markets: Narf Industries, Solvonis Therapeutic, BP & more

Small-cap Investing with Paul Hill and Paul Scott

Small-cap Investing with Paul Hill and Paul Scott

19 hours ago

In this week’s smallcap investing show, UK analyst & stock markets commentator Paul Scott & I discussed our latest thoughts 18 ideas.

AstraZeneca's Enhertu gets further EU approval

AstraZeneca's Enhertu gets further EU approval

3 hours ago

AstraZeneca and Daiichi Sankyo's Enhertu has been approved in the European Union as a monotherapy for the treatment of adult patients with unresectable or metastatic hormone receptor (HR)-positive, HER2-low or HER2-ultralow breast cancer, the companies said on Friday.

Mining Matters

The Exchange

Small-cap Investing

Company Q&A

    Most Followed Companies

    Watchlist